These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22634139)

  • 1. The effect of formulations and experimental conditions on in vitro human skin permeation-Data from updated EDETOX database.
    Samaras EG; Riviere JE; Ghafourian T
    Int J Pharm; 2012 Sep; 434(1-2):280-91. PubMed ID: 22634139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the effect of experimental variables on the in vitro permeation of six model compounds across porcine skin.
    Karadzovska D; Brooks JD; Riviere JE
    Int J Pharm; 2013 Feb; 443(1-2):58-67. PubMed ID: 23313919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the effect of mixture components on permeation through skin.
    Ghafourian T; Samaras EG; Brooks JD; Riviere JE
    Int J Pharm; 2010 Oct; 398(1-2):28-32. PubMed ID: 20643197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting skin permeability from complex vehicles.
    Karadzovska D; Brooks JD; Monteiro-Riviere NA; Riviere JE
    Adv Drug Deliv Rev; 2013 Feb; 65(2):265-77. PubMed ID: 22342772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of vehicle mixture effects on in vitro transdermal chemical flux using a random process diffusion model.
    Chittenden JT; Riviere JE
    J Control Release; 2015 Nov; 217():74-81. PubMed ID: 26282095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.
    Godin B; Touitou E
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes.
    Buist HE; van Burgsteden JA; Freidig AP; Maas WJ; van de Sandt JJ
    Regul Toxicol Pharmacol; 2010; 57(2-3):200-9. PubMed ID: 20178823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro dermal absorption rate testing of certain chemicals of interest to the Occupational Safety and Health Administration: summary and evaluation of USEPA's mandated testing.
    Fasano WJ; McDougal JN
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):181-94. PubMed ID: 18501488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validated models for predicting skin penetration from different vehicles.
    Ghafourian T; Samaras EG; Brooks JD; Riviere JE
    Eur J Pharm Sci; 2010 Dec; 41(5):612-6. PubMed ID: 20816954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of physicochemical properties in the estimation of skin permeability: in vitro data assessment by Partial Least-Squares Regression.
    Chauhan P; Shakya M
    SAR QSAR Environ Res; 2010 Jul; 21(5-6):481-94. PubMed ID: 20818583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
    Ottaviani G; Martel S; Carrupt PA
    J Med Chem; 2007 Feb; 50(4):742-8. PubMed ID: 17300161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in predicting skin permeability of hydrophilic solutes.
    Chen L; Han L; Lian G
    Adv Drug Deliv Rev; 2013 Feb; 65(2):295-305. PubMed ID: 22580335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin permeation: the years of enlightenment.
    Hadgraft J; Lane ME
    Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the potential of linear and nonlinear skin permeation models for the prediction of experimentally measured percutaneous drug absorption.
    Brown MB; Lau CH; Lim ST; Sun Y; Davey N; Moss GP; Yoo SH; De Muynck C
    J Pharm Pharmacol; 2012 Apr; 64(4):566-77. PubMed ID: 22420662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a correlation between drug properties and in vitro transdermal flux variability.
    Frum Y; Khan GM; Sefcik J; Rouse J; Eccleston GM; Meidan VM
    Int J Pharm; 2007 May; 336(1):140-7. PubMed ID: 17182201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure.
    Dancik Y; Miller MA; Jaworska J; Kasting GB
    Adv Drug Deliv Rev; 2013 Feb; 65(2):221-36. PubMed ID: 22285584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of penetrant and vehicle mixture properties on transdermal permeability using a mixed effect pharmacokinetic model of ex vivo porcine skin.
    Chittenden JT; Riviere JE
    Biopharm Drug Dispos; 2016 Oct; 37(7):387-396. PubMed ID: 27246159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.